Entourage Health Extends Senior Secured Credit Facility Maturity Date
Entourage Health Corp. confirmed today it has signed an additional amendment to its senior secured credit facility entered into on March 29, 2019.
Entourage Health Launches ‘Joints for Justice’ Retail Campaign to Raise Funds and Awareness in Support of Cannabis Amnesty
Pre-roll products available at Ontario retail stores via the Company’s craft brand Royal City Cannabis Co., with $1 of every pre-roll sold going to the advancement of Cannabis Amnesty’s initiatives
Entourage Appoints Finance Executive Vaani Maharaj as New Chief Financial Officer and Updates Timing of Q4 and Full-Year 2021 Financials to April 26
Entourage Health Corp. is pleased to announce the appointment of Vaani Maharaj, a seasoned financial executive with broad experience in corporate finance, healthcare and consumer-packaged goods (CPG).
Entourage Health Debuts New 2022 Color Cannabis Branding Campaign and Celebrates All-Female-Led Marketing and Promotions Team
On this International Women’s Day, the Company proudly spotlights its all-female trade and brand marketing team behind the 2022 launch of “Just add Color” anchored in colour theory
Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022
Company also provides a corporate update and confirms George Scorsis as permanent CEO
Entourage Health Launches New Premium Color Cannabis Products
Includes Ontario launch of specialty concentrate product “Pedro’s Sweet Sativa Live Sugar”; debut of high-THC, rare cultivar “Space Cake”; and “Black Sugar Rose 10-pack Pre-rolls”
Entourage Health Posts New Year 2022 Shareholder Newsletter
Entourage Health issued an open letter to shareholders today to provide a recap of its corporate and operational achievements attained over the past year, and an overview of what is expected in 2022.
Entourage Health and LiUNA Pension Fund Upsize Credit Facility with Additional $20 Million in Non-Dilutive Financing
Funding to enhance cultivation growth with tissue culture and market new genetics with premium products via Color Cannabis, Royal City Cannabis, Saturday Cannabis and Starseed Medicinal
Entourage Health Enhances Cultivation Platform with Tissue Culture IP and Introduces New Genetics for Premium Adult-Use and Medical Product Lineup in 2022
Company also confirms its certification as an Ontario Living Wage Employer, becoming one of only three cannabis cultivators with this distinction
Entourage Health Launches Cannabis-Infused Soft Chews for Starseed Medicinal Line
Company partners with Olli Brands Inc. to develop and curate a suite of premium CBD and THC soft chew products for release in its medical channel starting late November 2021
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth
Entourage Health Corp. announced today its financial results for the three and nine months ended September 30, 2021.
Entourage Health Enhances Executive Team with Key Strategic Appointments
Entourage Heath is pleased to announce it has further strengthened its executive team with strategic appointments in the areas of commercial sales, marketing, and business development as well as product development, cultivation and supply chain.
Entourage Health Closes Acquisition of Craft Cultivator CannTx Life Sciences Inc.
Closing of deal merges craft brand Royal City Cannabis Co. into Entourage’s product portfolio
Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET
Entourage Health Corp.is pleased to announce its preliminary unaudited total revenues of $14.7 million(1) for the three months ended September 30, 2021, representing another quarter of sequential record sales growth across its adult-use and medical sales channels.
Entourage Health Announces Filing of Amended Financial Statements and MD&A
Entourage Health Corp., today announces that, as a result of a continuous disclosure review conducted by staff of the Ontario Securities Commission (“OSC”), the staff of the Corporate Finance Branch requested that the Company refile its management's discussion and analysis (“MD&A”) for the interim periods ended March 31, 2021 and June 30, 2021 and its unaudited condensed interim consolidated financial statements for the three months ended March 31, 2021 (collectively, the "Revised Financial Disclosure").
Entourage Health Launches Mary’s Medicinals Transdermal Cannabis Patches in Canada
Innovative suite of Mary’s line-up produced locally now includes Transdermal Patches in CBD, THC and 1:1 formulations that offer a novel, alternative path to cannabinoid delivery
Entourage Health Launches Fire & Flower-branded CBD Softgel Product Line
Canada’s largest cannabis retailer Fire & Flower expands private-label portfolio with “Revity CBD Softgels” products added to its self-care lineup, produced exclusively by Entourage Health
Entourage Health Announces New Ticker Symbol on U.S.-Based OTCQX Market as ‘ETRGF’ Effective September 1, 2021
Entourage Health Corp. announced that effective at market open on September 1, 2021, the OTCQX market ticker symbol for the Company’s common shares will change from “WDDMF” to “ETRGF”.
Entourage Health Partners with Boston Beer Subsidiary to Launch and Sell Portfolio of Innovative Cannabis-Infused Beverages in Canada
Entourage holds exclusive rights to sell, market and distribute Boston Beer-branded and licensed non-alcoholic, cannabis beverages produced by Althea’s subsidiary Peak Processing
Entourage Health Expands its Saturday Cannabis Brand and Products into Quebec
Entourage Health is pleased to announce its adult-use brand Saturday Cannabis is now available for purchase in the Province of Quebec.